This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Guideline

. 2006:61 Suppl 82:1-20.

doi: 10.1111/j.1398-9995.2006.01219_1.x.

Standards for practical allergen-specific immunotherapy

E Alvarez-Cuesta, J Bousquet, G W Canonica, S R Durham, H-J Malling, E Valovirta; EAACI, Immunotherapy Task Force

PMID: 16930249
DOI: 10.1111/j.1398-9995.2006.01219_1.x

Guideline

Standards for practical allergen-specific immunotherapy

E Alvarez-Cuesta et al. Allergy. 2006.

. 2006:61 Suppl 82:1-20.

doi: 10.1111/j.1398-9995.2006.01219_1.x.

Authors

E Alvarez-Cuesta, J Bousquet, G W Canonica, S R Durham, H-J Malling, E Valovirta; EAACI, Immunotherapy Task Force

PMID: 16930249
DOI: 10.1111/j.1398-9995.2006.01219_1.x

No abstract available

PubMed Disclaimer

Comment in

EAACI 'Standards for practical allergen-specific immunotherapy'.
Madsen F. Madsen F. Allergy. 2007 Mar;62(3):332. doi: 10.1111/j.1398-9995.2007.01302.x. Allergy. 2007. PMID: 17298352 No abstract available.

Similar articles

EAACI 'Standards for practical allergen-specific immunotherapy'.
Madsen F. Madsen F. Allergy. 2007 Mar;62(3):332. doi: 10.1111/j.1398-9995.2007.01302.x. Allergy. 2007. PMID: 17298352 No abstract available.
Reply to the letter by Dr Fleming Madsen (EAACI 'Standards for practical allergen-specific immunotherapy').
Alvarez-Cuesta E, Bousquet J, Canonica WG, Durham S, Malling HJ, Passalacqua G, Valovirta E. Alvarez-Cuesta E, et al. Allergy. 2008 Jul;63(7):939-40. doi: 10.1111/j.1398-9995.2008.01648.x. Allergy. 2008. PMID: 18588562 No abstract available.
Standardization of allergen extracts.
Matthiesen F. Matthiesen F. Z Hautkr. 1988;63 Suppl 4:52-4. Z Hautkr. 1988. PMID: 3252626
Standardization of allergen-specific immunotherapy vaccines.
Spangfort MD, Larsen JN. Spangfort MD, et al. Immunol Allergy Clin North Am. 2006 May;26(2):191-206, v-vi. doi: 10.1016/j.iac.2006.02.012. Immunol Allergy Clin North Am. 2006. PMID: 16701140 Review.
Preparing and mixing allergen vaccines for subcutaneous immunotherapy.
Nelson HS. Nelson HS. Clin Allergy Immunol. 2008;21:303-20. Clin Allergy Immunol. 2008. PMID: 18828513 Review. No abstract available.

See all similar articles

Cited by

Safety and efficacy of rush allergen-specific immunotherapy in Chinese allergic rhinitis patients.
Qiu Q, Xu M, Lu C, Chen J, Chen S, Kong W, Han H. Qiu Q, et al. Int J Immunopathol Pharmacol. 2016 Dec;29(4):720-725. doi: 10.1177/0394632016659301. Epub 2016 Aug 10. Int J Immunopathol Pharmacol. 2016. PMID: 27510816 Free PMC article. Clinical Trial.
COVID-19 vaccination in patients receiving allergen immunotherapy (AIT) or biologicals-EAACI recommendations.
Jutel M, Torres MJ, Palomares O, Akdis CA, Eiwegger T, Untersmayr E, Barber D, Zemelka-Wiacek M, Kosowska A, Palmer E, Vieths S, Mahler V, Canonica WG, Nadeau K, Shamji MH, Agache I. Jutel M, et al. Allergy. 2022 Aug;77(8):2313-2336. doi: 10.1111/all.15252. Epub 2022 Mar 18. Allergy. 2022. PMID: 35147230 Free PMC article.
An EAACI "European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI)": the methodology.
Calderón MA, Rodríguez Del Río P, Vidal C, Just J, Pfaar O, Linneberg A, Demoly P. Calderón MA, et al. Clin Transl Allergy. 2014 Jul 21;4:22. doi: 10.1186/2045-7022-4-22. eCollection 2014. Clin Transl Allergy. 2014. PMID: 25075276 Free PMC article.
Perennial is more effective than preseasonal subcutaneous immunotherapy in the treatment of seasonal allergic rhinoconjunctivitis.
Tworek D, Bochenska-Marciniak M, Kuprys-Lipinska I, Kupczyk M, Kuna P. Tworek D, et al. Am J Rhinol Allergy. 2013 Jul-Aug;27(4):304-8. doi: 10.2500/ajra.2013.27.3935. Epub 2013 Apr 29. Am J Rhinol Allergy. 2013. PMID: 23636036 Free PMC article. Clinical Trial.
Simultaneous Influenza Vaccination and Hymenoptera Venom Immunotherapy Is Safe.
Czerwińska E, Nittner-Marszalska M, Pawłowicz R, Szenborn L. Czerwińska E, et al. Vaccines (Basel). 2021 Apr 2;9(4):344. doi: 10.3390/vaccines9040344. Vaccines (Basel). 2021. PMID: 33918358 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- ClinicalTrials.gov